Trials / Active Not Recruiting
Active Not RecruitingNCT01983410
A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to better understand why pancreatic cancer develops in some people who are known carriers of the gene mutation (an abnormality) called BRCA, or its close relative PALB2. The investigators hope to do this by establishing a BRCA/PALB2 mutation carriers Pancreatic Ductal Adenocarcinoma (the common form of pancreatic cancer) Registry. A registry is a database of information.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | The risk assessment questionnaire | |
| OTHER | Blood specimens | |
| OTHER | tumor tissue samples will be requested |
Timeline
- Start date
- 2013-11-04
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2013-11-14
- Last updated
- 2025-12-30
Locations
13 sites across 2 countries: United States, Israel
Source: ClinicalTrials.gov record NCT01983410. Inclusion in this directory is not an endorsement.